Additional Warnings For V.A.C. Veraflo™ Therapy; A�C�Ulta™ Therapy System Precautions - KCI V.A.C.Ulta Manual Del Usuario

Non-clinical testing under these same conditions produced a temperature rise of <0�4°C� MR
image quality may be compromised if the area of interest is in the same area or relatively close to
the position of the V�A�C� GranuFoam Silver
hyperbaric oxygen therapy (hbo): Do not take the V�A�C�Ulta™ Therapy Unit into a
hyperbaric oxygen chamber� The V�A�C�Ulta™ Therapy Unit is not designed for this environment,
and should be considered a fire hazard� After disconnecting the V�A�C�Ulta™ Therapy Unit, either
(i) replace the V�A�C� Dressing or V�A�C� VeraFlo™ Therapy Dressing with another HBO compatible
®
material during the hyperbaric treatment, or (ii) cover the unclamped end of the V�A�C�
with moist cotton gauze and completely cover the V�A�C�
Dressing (including tubing) with a moist towel throughout the treatment in the chamber� For HBO
therapy, the V�A�C� Tubing or V�A�C� VeraFlo™ Therapy tubing must not be clamped� Never leave
®
a V�A�C� ® Dressing in place without active V�A�C�
the Keep V.A.C. therapy on section above�
®
Note: If using V.A.C. VeraFlo™ Therapy ensure that irrigation fluid or
treatment solutions are fully removed from the dressing prior to stopping
negative pressure wound therapy.
AdditioNAl WArNiNgs for V.A.C. VerAflo™ therAPy
topical Wound solutions: Topical wound solutions or suspensions may enter
internal body cavities if the wound is open to such cavities� They should not be
infused into wounds with unexplored tunnels or unexplored undermining as they
may enter into unintended cavities�
Pauses in Negative Pressure: Application of V�A�C� VeraFlo™ Therapy will result
in pauses of negative pressure wound therapy, which is not recommended on
wounds requiring continuous V�A�C�
over unstable structures, such as unstable chest wall or non-intact fascia, on
patients at increased risk of bleeding, highly exudating wounds, on flaps, grafts or
wounds with acute enteric fistulae�
bioengineered tissue: V�A�C� VeraFlo™ Therapy is not intended for use with
cellular or accellular bioengineered tissues�
hemostasis: Patients with difficult or fragile wound hemostasis are at increased
risk of bleeding associated with V�A�C� VeraFlo™ Therapy due to the potential
for disruption of clots or dilution of clotting factors� Do not use V�A�C� VeraFlo™
Therapy where hemostatic agents have been used in the wound bed�
V.A.C.UltA™ therAPy system PreCAUtioNs
standard Precautions: To reduce the risk of transmission of bloodborne pathogens, apply
standard precautions for infection control with all patients, per institutional protocol, regardless
of their diagnosis or presumed infection status� In addition to gloves, use gown and goggles if
exposure to body fluids is likely�
dressing�
®
® Dressing or V�A�C� VeraFlo™ Therapy
® Therapy for more than 2 hours; please refer to
Therapy� Do not use V�A�C� VeraFlo™ Therapy
®
8
Tubing
®